tradingkey.logo
tradingkey.logo
検索

Abbott Laboratories

ABT
ウォッチリストに追加
114.140USD
-0.290-0.25%
終値 08-20 16:00ET
197.61B時価総額
31.69直近12ヶ月PER

詳細情報 Abbott Laboratories 企業名

Abbott Laboratories is a global healthcare company. The Company’s principal business is the discovery, development, manufacture, and sale of a broad and diversified line of healthcare products. Its segments include Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. Established Pharmaceutical Products segment is engaged in the international sales of a broad line of branded generic pharmaceutical products. Diagnostic Products segment is involved in the worldwide sales of diagnostic systems and tests for blood banks, hospitals, commercial laboratories and alternate-care testing sites. Nutritional Products segment is engaged in the worldwide sales of a broad line of adult and pediatric nutritional products. Medical Devices segment is involved in the worldwide sales of rhythm management, electrophysiology, heart failure, vascular, structural heart, neuromodulation and diabetes care products. It serves people in more than 160 countries.

Abbott Laboratories プロフィール

企業コードABT
会社名Abbott Laboratories
上場日Apr 06, 2073
最高経営責任者「CEO」Ford (Robert B)
従業員数114000
証券種類Ordinary Share
決算期末Apr 06
本社所在地100 Abbott Park Road
都市ABBOTT PARK
証券取引所NASDAQ OMX NASDAQ Basic NYSE
United States of America
郵便番号60064-3500
電話番号12246676100
ウェブサイトhttps://www.abbott.com
企業コードABT
上場日Apr 06, 2073
最高経営責任者「CEO」Ford (Robert B)

Abbott Laboratoriesの経営陣

会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Daniel J. Starks
Mr. Daniel J. Starks
Independent Director
Independent Director
6.75M
+0.18%
Mr. Daniel Gesua Sive Salvadori
Mr. Daniel Gesua Sive Salvadori
Executive Vice President and Group President - Established Pharmaceuticals and Nutritional Products
Executive Vice President and Group President - Established Pharmaceuticals and Nutritional Products
146.38K
-0.60%
Ms. Mary K. Moreland
Ms. Mary K. Moreland
Executive Vice President - Human Resources
Executive Vice President - Human Resources
104.29K
-0.59%
Ms. Lisa D. Earnhardt
Ms. Lisa D. Earnhardt
Executive Vice President and Group President - Medical Devices
Executive Vice President and Group President - Medical Devices
90.41K
+20.44%
Mr. Christopher J. Scoggins
Mr. Christopher J. Scoggins
Executive Vice President - Diabetes Care
Executive Vice President - Diabetes Care
77.13K
+17.51%
Mr. Philip P. Boudreau
Mr. Philip P. Boudreau
Executive Vice President - Finance and Chief Financial Officer
Executive Vice President - Finance and Chief Financial Officer
71.54K
+28.74%
Mr. Louis H. (Lou) Morrone
Mr. Louis H. (Lou) Morrone
Executive Vice President - Core Diagnostics
Executive Vice President - Core Diagnostics
70.72K
-8.27%
Ms. Nancy McKinstry
Ms. Nancy McKinstry
Lead Independent Director
Lead Independent Director
41.01K
+5.57%
Dr. Robert J. Alpern, M.D.
Dr. Robert J. Alpern, M.D.
Independent Director
Independent Director
40.80K
--
Mr. Eric Shroff
Mr. Eric Shroff
Senior Vice President - Rapid and Molecular Diagnostics
Senior Vice President - Rapid and Molecular Diagnostics
39.16K
-1.81%
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Daniel J. Starks
Mr. Daniel J. Starks
Independent Director
Independent Director
6.75M
+0.18%
Mr. Daniel Gesua Sive Salvadori
Mr. Daniel Gesua Sive Salvadori
Executive Vice President and Group President - Established Pharmaceuticals and Nutritional Products
Executive Vice President and Group President - Established Pharmaceuticals and Nutritional Products
146.38K
-0.60%
Ms. Mary K. Moreland
Ms. Mary K. Moreland
Executive Vice President - Human Resources
Executive Vice President - Human Resources
104.29K
-0.59%
Ms. Lisa D. Earnhardt
Ms. Lisa D. Earnhardt
Executive Vice President and Group President - Medical Devices
Executive Vice President and Group President - Medical Devices
90.41K
+20.44%
Mr. Christopher J. Scoggins
Mr. Christopher J. Scoggins
Executive Vice President - Diabetes Care
Executive Vice President - Diabetes Care
77.13K
+17.51%
Mr. Philip P. Boudreau
Mr. Philip P. Boudreau
Executive Vice President - Finance and Chief Financial Officer
Executive Vice President - Finance and Chief Financial Officer
71.54K
+28.74%

よくある質問

Abbott Laboratoriesの上位5名の株主は誰ですか?

Abbott Laboratoriesの上位5名の株主は以下のとおりです。Mr. Daniel J. Starks

Abbott Laboratories(ABT)の株式を保有している機関の数はいくつですか?

2026Q1時点で、Abbott Laboratoriesの株式を保有している機関は4859社あり、保有株式の総市場価値は約1.25Bで、全体の71.75%を占めています。2025Q4と比較して、機関の持ち株は-187252308.00増加しています。

Abbott Laboratoriesの最大の収益源は何ですか?

2026Q1において、Diabetes Care部門がAbbott Laboratoriesにとって最大の収益を生み出しており、その金額は8.00Bで、全収益の18.04%を占めています。
tradingkey.logo
リスク告知:当社ウェブサイト及びモバイルアプリは特定の投資商品に関する一般的な情報のみを提供しており、Finsightsは金融アドバイスや投資商品の推奨を行うものではありません。本情報の提供をもってFinsightsが投資助言を行っていると解釈されることはありません。
投資商品には元本割れを含む重大なリスクが伴い、全ての投資家に適するものではありません。なお、過去の運用実績は将来の成果を保証するものではありません。
Finsightsは、第三者広告主または提携先が当社ウェブサイト・モバイルアプリ上に広告を掲載することを許可する場合があり、これら広告主から広告への反応に基づく報酬を受けることがあります。
© 著作権: FINSIGHTS MEDIA PTE. LTD. 無断複写・転載を禁じます。